DSP-5336, an Investigational Menin and Mixed-lineage Leukemia Inhibitor, is Being Evaluated in Patients with Relapsed or Refractory Acute Leukemia
Comprehensive clinical development programs being initiated for each investigational candidate
Presentations include new data on investigational medicines – favezelimab (MK-4280), zilovertamab vedotin (MK-2140) and nemtabrutinib – as well as KEYTRUDA (pembrolizumab) in multiple blood cancers
The leading cancer hospital urges carrier screening to prevent thalassemia burden
The facility combines advanced diagnostics, bone marrow transplant evaluation, prenatal awareness, and multidisciplinary support services
The initiative by DKMS Foundation India is for below 12 years children suffering from transfusion-dependent thalassemia
But acquisition charges drag earnings into loss
The summit will bring together 1,200+ delegates, 100+ international faculty from 25 countries
The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack
Subscribe To Our Newsletter & Stay Updated
